- RecruitingPHASE3
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
This study looks at new and existing medicines (CagriSema and Semaglutide) to help people with obesity, sometimes with type 2 diabetes, lose weight. Researchers want to see how safe and effective these medicines are. It lasts about 83 weeks.
For: Obesity · Type 2 DiabetesUnited States · Argentina · Australia - Not yet recruitingPHASE3
A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
This study tests whether a new medicine called CagriSema can safely lower high blood pressure in adults living with obesity. Participants are randomly chosen to receive either CagriSema, semaglutide, cagrilintide, or a dummy treatment (placebo). Researchers will monitor how well each treatment works over time.
For: Hypertension · ObesityUnited States · Argentina · Australia